Press Releases
June 24, 2026
Exo-Top, NurExone’s wholly owned U.S. Subsidiary, Enters Into Binding MOU For Naïve Exosome Distribution in Mexico
June 1, 2026
NurExone Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 27, 2026
NurExone Receives Notice of Patent Grant in South Korea Covering ExoPTEN Technology
May 14, 2026
NurExone Advances to Stage 2 of EU-Backed EIT Health Catapult Programme 2026
April 28, 2026
Australian Patent Granted to NurExone Covering Stem Cell-Derived Exosome Production
April 26, 2026
The Biotech Event Accelerating Fresh Ideas, Partnerships and Opportunities 2026
April 16, 2026
NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update
April 7, 2026
NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization
April 1, 2026